Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Myosin phosphatase modulates the cardiac cell fate by regulating the subcellular localization of Nkx2 5 in a Wnt/Rho-associated protein kinase-dependent pathway Ryan T; Shelton M; Lambert JP; Malecova B; Boisvenue S; Ruel M; Figeys D; Puri PL; Skerjanc ISCirc Res 2013[Jan]; 112 (2): 257-66RATIONALE: Nkx2.5 is a transcription factor that regulates cardiomyogenesis in vivo and in embryonic stem cells. It is also a common target in congenital heart disease. Although Nkx2.5 has been implicated in the regulation of many cellular processes that ultimately contribute to cardiomyogenesis and morphogenesis of the mature heart, relatively little is known about how it is regulated at a functional level. OBJECTIVE: We have undertaken a proteomic screen to identify novel binding partners of Nkx2.5 during cardiomyogenic differentiation in an effort to better understand the regulation of its transcriptional activity. METHODS AND RESULTS: Purification of Nkx2.5 from differentiating cells identified the myosin phosphatase subunits protein phosphatase 1beta and myosin phosphatase targeting subunit 1 (Mypt1) as novel binding partners. The interaction with protein phosphatase 1 beta/Mypt1 resulted in exclusion of Nkx2.5 from the nucleus and, consequently, inhibition of its transcriptional activity. Exclusion of Nkx2.5 was inhibited by treatment with leptomycin B and was dependent on an Mypt1 nuclear export signal. Furthermore, in transient transfection experiments, Nkx2.5 colocalized outside the nucleus with phosphorylated Mypt1 in a manner dependent on Wnt signaling and Rho-associated protein kinase. Treatment of differentiating mouse embryonic stem cells with Wnt3a resulted in enhanced phosphorylation of endogenous Mypt1, increased nuclear exclusion of endogenous Nkx2.5, and a failure to undergo terminal cardiomyogenesis. Finally, knockdown of Mypt1 resulted in rescue of Wnt3a-mediated inhibition of cardiomyogenesis, indicating that Mypt1 is required for this process. CONCLUSIONS: We have identified a novel interaction between Nkx2.5 and myosin phosphatase. Promoting this interaction represents a novel mechanism whereby Wnt3a regulates Nkx2.5 and inhibits cardiomyogenesis.|Animals[MESH]|Embryonic Stem Cells/enzymology/metabolism/physiology[MESH]|Growth Inhibitors/*physiology[MESH]|HEK293 Cells[MESH]|Homeobox Protein Nkx-2.5[MESH]|Homeodomain Proteins/*metabolism[MESH]|Humans[MESH]|Mice[MESH]|Myocytes, Cardiac/enzymology/metabolism/*physiology[MESH]|Myosin-Light-Chain Phosphatase/metabolism/*physiology[MESH]|Protein Phosphatase 1/metabolism[MESH]|Signal Transduction/*physiology[MESH]|Subcellular Fractions/enzymology/metabolism[MESH]|Transcription Factors/*metabolism[MESH]|Wnt Signaling Pathway/*physiology[MESH]|Wnt3A Protein/*physiology[MESH]|rho-Associated Kinases/*physiology[MESH] |
